27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
27-Inch Endoscopic Imaging Monitor: Use of a 27-inch 4K-2D endoscopic imaging monitor during minimally invasive endometrial cancer surgery.
55-Inch Endoscopic Imaging Monitor: Use of a 55-inch 4K-2D endoscopic imaging monitor during minimally invasive endometrial cancer surgery.
Study summary
This study will compare the use of 27-inch and 55-inch endoscopic imaging monitors during minimally invasive surgery for women with endometrial cancer. Participants will be randomly assigned to one of the two monitor groups. All participants will undergo the same standard surgical procedure; only the monitor size used during surgery will differ. The main question is whether monitor size affects total operative time. The study will also evaluate sentinel lymph node dissection time, blood count changes, complications, infections, hospital stay, and drain-related outcomes during the first 30 days after surgery.
Eligibility
Primary outcome measure(s)
- Total Operative Time — During surgery
Total operative time, defined as the time from entry of the laparoscopic optic into the abdomen after trocar placement to completion of surgery, measured in minutes.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Basaksehir Cam and Sakura City Hospital | Istanbul | Istanbul |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07882277 on ClinicalTrials.gov ↗ ← All trials in Turkey